Ibogaine in Germany

Two statutes, and everyone reads only one

The German position is routinely reported as “iboga is legal in Germany”. The claim comes from checking the right law and stopping.

The Betäubungsmittelgesetz, the narcotics act, does not list ibogaine or iboga root bark in its annexes. There is no narcotics offence. That much is true, and it is where most accounts end.

The Arzneimittelgesetz, the medicines act, is the one that governs. No ibogaine product holds a German marketing authorisation, and under §96 placing an unapproved medicine on the market is an offence. More seriously, §5 prohibits placing an unsafe medicine on the market or administering it to another person, and §95 sets up to three years for that, rising to between one and ten years where the conduct exposes someone to a risk of death. Given the documented cardiac deaths, §5 is the provision a German facility would be operating against.

What follows for a German reader

Ordering from abroad is the exposed act. §73 restricts bringing medicines into Germany. Two exceptions could matter: a quantity matching ordinary personal need carried in on entry, and the same quantity obtained without commercial intermediation from an EU or EEA state where the medicine may lawfully be marketed. No EU or EEA state permits ibogaine to be marketed as a medicine, so neither exception reaches a shipment from a seller. Breaching §73 is a regulatory offence under §97, punishable by a fine of up to €25,000, rather than a crime. Commercial import without a licence under §72 is a crime under §96.

There is no lawful clinic. Administering ibogaine to a patient means using an unapproved medicine for therapeutic purposes. The routes that exist for unapproved medicines, a pharmacy preparation on prescription under §21 or a single-patient import through a pharmacy under §73, all run into §5, which bans administering an unsafe medicine outright and admits no exception. A facility offering it in Germany is not operating in a grey area of narcotics law; it is operating against medicines law.

Nobody is required to screen you. Because no clinical regime applies, no rule requires an ECG before administration or cardiac monitoring during it. The danger is unaffected by which statute happens to cover the substance.

The other law people forget

Germany’s Neue-psychoaktive-Stoffe-Gesetz works through two annexes: one defines whole chemical families, the other names individual substances. One of the families covers tryptamines. Ibogaine’s indole structure invites a wrong answer here, and it is the same trap that produces false claims about Norway.

On our reading of the annex it falls outside the group. Its amine nitrogen sits in a bridged bicyclic ring that the definition does not list among the permitted ring systems, and its indole is fused at a position where the definition does not allow substitution. That is our structural reading, not a regulator’s determination: we found no published decision either way.

There is also a prior question. §1 of that Act disapplies it entirely to medicinal products, and a substance offered as a treatment for addiction is a medicinal product. On the reading this page takes, the psychoactive substances act never reaches ibogaine at all.

Germany, the Netherlands, and the same shape

Germany’s neighbour reached a comparable position and then did something Germany has not: it studied the substance.

At the Dutch health ministry’s request, the national public health institute assessed iboga preparations in 2024 and advised consumers not to use them, citing heart-rhythm disturbance and deaths including in the Netherlands. Nothing equivalent exists on the German side, which means the most useful official document for a German reader was written in another country.

Its findings apply regardless of the border. The products are the same, the online sellers overlap, and the cardiac mechanism does not check passports.

Germany in context

Germany belongs with the Netherlands among countries that never brought ibogaine into narcotics law, and with the United Kingdom among those where the supply chain is nonetheless closed. Unlike Britain, it has no domestic regulatory statement on ibogaine at all.

See the status by country table for the full picture, and the Netherlands for the assessment Germany has not made.